If you have been wondering whether Johnson & Johnson is fairly priced or offering value right now, this article will walk ...

In the nearly nine months spanning from May 2025 to February 2026, Johnson & Johnson (JNJ)’s stock experienced a remarkable ...

Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

Johnson & Johnson's (NYSE: JNJ) stock price is up more than 7% since the first trading day of November. What's going on with this healthcare giant? Well, J&J posted strong third-quarter results in mid ...

Last month, Johnson & Johnson surged following a well-received quarterly earnings release. Despite a sluggish start to November, a spate of positive news has since sent the healthcare stock's shares ...

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does ...

Why Johnson & Johnson (JNJ) is Back on Investors’ Radar Johnson & Johnson (JNJ) has drawn fresh attention after recent ...

The average one-year price target for Johnson & Johnson (WBAG:JNJ) has been revised to € 175,20 / share. This is an increase of 11.73% from the prior estimate of € 156,80 dated September 29, 2025. The ...

Fintel reports that on January 28, 2026, Morgan Stanley upgraded their outlook for Johnson & Johnson (NYSE:JNJ) from ...

Weekly insider trading recap (Jan 26–30, 2025): major JNJ, MU, GS & MS sales plus INTC, ABT, GME and IBM buys—see key signals now.

J&J beat Wall Street estimates on sales and profits in the third quarter. The company recently announced the acquisition of a biotech with an innovative cancer treatment. 10 stocks we like better than ...